Industry Research Reports

Home > Reports > Medical Devices & Consumables > Thromboresistant Coatings - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Thromboresistant Coatings - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-03-10

Pages: 110 Pages

Report ld: 4619014

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Thromboresistant Coatings Market Size(US$)

CAGR 2025-2031

6.3%

Market Size,2031

USD 2,050

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,421 million

Market Forecast in 2031(Value)

US$ 2,050 million

CAGR

6.3%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Thromboresistant Coatings was estimated to be worth US$ 1345 million in 2024 and is forecast to a readjusted size of US$ 2050 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.

Thromboresistant coatings are specialized surface treatments applied to medical devices and implants, such as stents, catheters, and vascular grafts, to reduce the risk of blood clot formation. These coatings are designed to mimic the natural anti-thrombogenic properties of blood vessels, minimizing platelet adhesion and activation. Commonly made from biocompatible materials like heparin, hydrogels, or synthetic polymers, they enhance the safety and effectiveness of devices used in cardiovascular and other blood-contact applications. By preventing thrombosis, these coatings improve patient outcomes and extend the functionality of medical devices.

North American market for Thromboresistant Coatings was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Thromboresistant Coatings was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Thromboresistant Coatings was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Thromboresistant Coatings include Biointeractions, Hydromer, WL Gore & Associates, Toyobo, TekCyte, Surmodics, Corline Biomedical, Biomerics, Noanix, AST Products, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Thromboresistant Coatings, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Thromboresistant Coatings by region & country, by Type, and by Application.

The Thromboresistant Coatings market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thromboresistant Coatings.

MARKET SEGMENTATION

By Company

Biointeractions
Hydromer
WL Gore & Associates
Toyobo
TekCyte
Surmodics
Corline Biomedical
Biomerics
Noanix
AST Products
jMedtech
Biosurf

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Active Anti-thrombogenic Coating
Inert Anti-thrombogenic Coating

Segment by Application

Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Thromboresistant Coatings company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Thromboresistant Coatings in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Thromboresistant Coatings in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Thromboresistant Coatings Product Introduction

1.2 Global Thromboresistant Coatings Market Size Forecast (2020-2031)

1.3 Thromboresistant Coatings Market Trends & Drivers

1.3.1 Thromboresistant Coatings Industry Trends

1.3.2 Thromboresistant Coatings Market Drivers & Opportunity

1.3.3 Thromboresistant Coatings Market Challenges

1.3.4 Thromboresistant Coatings Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Thromboresistant Coatings Players Revenue Ranking (2024)

2.2 Global Thromboresistant Coatings Revenue by Company (2020-2025)

2.3 Key Companies Thromboresistant Coatings Manufacturing Base Distribution and Headquarters

2.4 Key Companies Thromboresistant Coatings Product Offered

2.5 Key Companies Time to Begin Mass Production of Thromboresistant Coatings

2.6 Thromboresistant Coatings Market Competitive Analysis

2.6.1 Thromboresistant Coatings Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Thromboresistant Coatings Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thromboresistant Coatings as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Active Anti-thrombogenic Coating

3.1.2 Inert Anti-thrombogenic Coating

3.2 Global Thromboresistant Coatings Sales Value by Type

3.2.1 Global Thromboresistant Coatings Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Thromboresistant Coatings Sales Value, by Type (2020-2031)

3.2.3 Global Thromboresistant Coatings Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cardiovascular Devices

4.1.2 Catheters and Cannulas

4.1.3 Dialysis and Extracorporeal Circuits

4.1.4 Others

4.2 Global Thromboresistant Coatings Sales Value by Application

4.2.1 Global Thromboresistant Coatings Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Thromboresistant Coatings Sales Value, by Application (2020-2031)

4.2.3 Global Thromboresistant Coatings Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Thromboresistant Coatings Sales Value by Region

5.1.1 Global Thromboresistant Coatings Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Thromboresistant Coatings Sales Value by Region (2020-2025)

5.1.3 Global Thromboresistant Coatings Sales Value by Region (2026-2031)

5.1.4 Global Thromboresistant Coatings Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Thromboresistant Coatings Sales Value, 2020-2031

5.2.2 North America Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Thromboresistant Coatings Sales Value, 2020-2031

5.3.2 Europe Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Thromboresistant Coatings Sales Value, 2020-2031

5.4.2 Asia Pacific Thromboresistant Coatings Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Thromboresistant Coatings Sales Value, 2020-2031

5.5.2 South America Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Thromboresistant Coatings Sales Value, 2020-2031

5.6.2 Middle East & Africa Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Thromboresistant Coatings Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Thromboresistant Coatings Sales Value, 2020-2031

6.3 United States

6.3.1 United States Thromboresistant Coatings Sales Value, 2020-2031

6.3.2 United States Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Thromboresistant Coatings Sales Value, 2020-2031

6.4.2 Europe Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Thromboresistant Coatings Sales Value, 2020-2031

6.5.2 China Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.5.3 China Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Thromboresistant Coatings Sales Value, 2020-2031

6.6.2 Japan Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Thromboresistant Coatings Sales Value, 2020-2031

6.7.2 South Korea Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Thromboresistant Coatings Sales Value, 2020-2031

6.8.2 Southeast Asia Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Thromboresistant Coatings Sales Value, 2020-2031

6.9.2 India Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

6.9.3 India Thromboresistant Coatings Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Biointeractions

7.1.1 Biointeractions Profile

7.1.2 Biointeractions Main Business

7.1.3 Biointeractions Thromboresistant Coatings Products, Services and Solutions

7.1.4 Biointeractions Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.1.5 Biointeractions Recent Developments

7.2 Hydromer

7.2.1 Hydromer Profile

7.2.2 Hydromer Main Business

7.2.3 Hydromer Thromboresistant Coatings Products, Services and Solutions

7.2.4 Hydromer Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.2.5 Hydromer Recent Developments

7.3 WL Gore & Associates

7.3.1 WL Gore & Associates Profile

7.3.2 WL Gore & Associates Main Business

7.3.3 WL Gore & Associates Thromboresistant Coatings Products, Services and Solutions

7.3.4 WL Gore & Associates Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.3.5 WL Gore & Associates Recent Developments

7.4 Toyobo

7.4.1 Toyobo Profile

7.4.2 Toyobo Main Business

7.4.3 Toyobo Thromboresistant Coatings Products, Services and Solutions

7.4.4 Toyobo Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.4.5 Toyobo Recent Developments

7.5 TekCyte

7.5.1 TekCyte Profile

7.5.2 TekCyte Main Business

7.5.3 TekCyte Thromboresistant Coatings Products, Services and Solutions

7.5.4 TekCyte Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.5.5 TekCyte Recent Developments

7.6 Surmodics

7.6.1 Surmodics Profile

7.6.2 Surmodics Main Business

7.6.3 Surmodics Thromboresistant Coatings Products, Services and Solutions

7.6.4 Surmodics Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.6.5 Surmodics Recent Developments

7.7 Corline Biomedical

7.7.1 Corline Biomedical Profile

7.7.2 Corline Biomedical Main Business

7.7.3 Corline Biomedical Thromboresistant Coatings Products, Services and Solutions

7.7.4 Corline Biomedical Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.7.5 Corline Biomedical Recent Developments

7.8 Biomerics

7.8.1 Biomerics Profile

7.8.2 Biomerics Main Business

7.8.3 Biomerics Thromboresistant Coatings Products, Services and Solutions

7.8.4 Biomerics Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.8.5 Biomerics Recent Developments

7.9 Noanix

7.9.1 Noanix Profile

7.9.2 Noanix Main Business

7.9.3 Noanix Thromboresistant Coatings Products, Services and Solutions

7.9.4 Noanix Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.9.5 Noanix Recent Developments

7.10 AST Products

7.10.1 AST Products Profile

7.10.2 AST Products Main Business

7.10.3 AST Products Thromboresistant Coatings Products, Services and Solutions

7.10.4 AST Products Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.10.5 AST Products Recent Developments

7.11 jMedtech

7.11.1 jMedtech Profile

7.11.2 jMedtech Main Business

7.11.3 jMedtech Thromboresistant Coatings Products, Services and Solutions

7.11.4 jMedtech Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.11.5 jMedtech Recent Developments

7.12 Biosurf

7.12.1 Biosurf Profile

7.12.2 Biosurf Main Business

7.12.3 Biosurf Thromboresistant Coatings Products, Services and Solutions

7.12.4 Biosurf Thromboresistant Coatings Revenue (US$ Million) & (2020-2025)

7.12.5 Biosurf Recent Developments

8 Industry Chain Analysis

8.1 Thromboresistant Coatings Industrial Chain

8.2 Thromboresistant Coatings Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Thromboresistant Coatings Sales Model

8.5.2 Sales Channel

8.5.3 Thromboresistant Coatings Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Thromboresistant Coatings Market Trends

Table 2. Thromboresistant Coatings Market Drivers & Opportunity

Table 3. Thromboresistant Coatings Market Challenges

Table 4. Thromboresistant Coatings Market Restraints

Table 5. Global Thromboresistant Coatings Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Thromboresistant Coatings Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Thromboresistant Coatings Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Thromboresistant Coatings Product Type

Table 9. Key Companies Time to Begin Mass Production of Thromboresistant Coatings

Table 10. Global Thromboresistant Coatings Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thromboresistant Coatings as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Thromboresistant Coatings Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Thromboresistant Coatings Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Thromboresistant Coatings Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Thromboresistant Coatings Sales Market Share in Value by Type (2020-2025)

Table 17. Global Thromboresistant Coatings Sales Market Share in Value by Type (2026-2031)

Table 18. Global Thromboresistant Coatings Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Thromboresistant Coatings Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Thromboresistant Coatings Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Thromboresistant Coatings Sales Market Share in Value by Application (2020-2025)

Table 22. Global Thromboresistant Coatings Sales Market Share in Value by Application (2026-2031)

Table 23. Global Thromboresistant Coatings Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Thromboresistant Coatings Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Thromboresistant Coatings Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Thromboresistant Coatings Sales Value by Region (2020-2025) & (%)

Table 27. Global Thromboresistant Coatings Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Thromboresistant Coatings Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Thromboresistant Coatings Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Thromboresistant Coatings Sales Value, (2026-2031) & (US$ Million)

Table 31. Biointeractions Basic Information List

Table 32. Biointeractions Description and Business Overview

Table 33. Biointeractions Thromboresistant Coatings Products, Services and Solutions

Table 34. Revenue (US$ Million) in Thromboresistant Coatings Business of Biointeractions (2020-2025)

Table 35. Biointeractions Recent Developments

Table 36. Hydromer Basic Information List

Table 37. Hydromer Description and Business Overview

Table 38. Hydromer Thromboresistant Coatings Products, Services and Solutions

Table 39. Revenue (US$ Million) in Thromboresistant Coatings Business of Hydromer (2020-2025)

Table 40. Hydromer Recent Developments

Table 41. WL Gore & Associates Basic Information List

Table 42. WL Gore & Associates Description and Business Overview

Table 43. WL Gore & Associates Thromboresistant Coatings Products, Services and Solutions

Table 44. Revenue (US$ Million) in Thromboresistant Coatings Business of WL Gore & Associates (2020-2025)

Table 45. WL Gore & Associates Recent Developments

Table 46. Toyobo Basic Information List

Table 47. Toyobo Description and Business Overview

Table 48. Toyobo Thromboresistant Coatings Products, Services and Solutions

Table 49. Revenue (US$ Million) in Thromboresistant Coatings Business of Toyobo (2020-2025)

Table 50. Toyobo Recent Developments

Table 51. TekCyte Basic Information List

Table 52. TekCyte Description and Business Overview

Table 53. TekCyte Thromboresistant Coatings Products, Services and Solutions

Table 54. Revenue (US$ Million) in Thromboresistant Coatings Business of TekCyte (2020-2025)

Table 55. TekCyte Recent Developments

Table 56. Surmodics Basic Information List

Table 57. Surmodics Description and Business Overview

Table 58. Surmodics Thromboresistant Coatings Products, Services and Solutions

Table 59. Revenue (US$ Million) in Thromboresistant Coatings Business of Surmodics (2020-2025)

Table 60. Surmodics Recent Developments

Table 61. Corline Biomedical Basic Information List

Table 62. Corline Biomedical Description and Business Overview

Table 63. Corline Biomedical Thromboresistant Coatings Products, Services and Solutions

Table 64. Revenue (US$ Million) in Thromboresistant Coatings Business of Corline Biomedical (2020-2025)

Table 65. Corline Biomedical Recent Developments

Table 66. Biomerics Basic Information List

Table 67. Biomerics Description and Business Overview

Table 68. Biomerics Thromboresistant Coatings Products, Services and Solutions

Table 69. Revenue (US$ Million) in Thromboresistant Coatings Business of Biomerics (2020-2025)

Table 70. Biomerics Recent Developments

Table 71. Noanix Basic Information List

Table 72. Noanix Description and Business Overview

Table 73. Noanix Thromboresistant Coatings Products, Services and Solutions

Table 74. Revenue (US$ Million) in Thromboresistant Coatings Business of Noanix (2020-2025)

Table 75. Noanix Recent Developments

Table 76. AST Products Basic Information List

Table 77. AST Products Description and Business Overview

Table 78. AST Products Thromboresistant Coatings Products, Services and Solutions

Table 79. Revenue (US$ Million) in Thromboresistant Coatings Business of AST Products (2020-2025)

Table 80. AST Products Recent Developments

Table 81. jMedtech Basic Information List

Table 82. jMedtech Description and Business Overview

Table 83. jMedtech Thromboresistant Coatings Products, Services and Solutions

Table 84. Revenue (US$ Million) in Thromboresistant Coatings Business of jMedtech (2020-2025)

Table 85. jMedtech Recent Developments

Table 86. Biosurf Basic Information List

Table 87. Biosurf Description and Business Overview

Table 88. Biosurf Thromboresistant Coatings Products, Services and Solutions

Table 89. Revenue (US$ Million) in Thromboresistant Coatings Business of Biosurf (2020-2025)

Table 90. Biosurf Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Thromboresistant Coatings Downstream Customers

Table 94. Thromboresistant Coatings Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Thromboresistant Coatings Product Picture

Figure 2. Global Thromboresistant Coatings Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Thromboresistant Coatings Sales Value (2020-2031) & (US$ Million)

Figure 4. Thromboresistant Coatings Report Years Considered

Figure 5. Global Thromboresistant Coatings Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Thromboresistant Coatings Revenue in 2024

Figure 7. Thromboresistant Coatings Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Active Anti-thrombogenic Coating Picture

Figure 9. Inert Anti-thrombogenic Coating Picture

Figure 10. Global Thromboresistant Coatings Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Thromboresistant Coatings Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Cardiovascular Devices

Figure 13. Product Picture of Catheters and Cannulas

Figure 14. Product Picture of Dialysis and Extracorporeal Circuits

Figure 15. Product Picture of Others

Figure 16. Global Thromboresistant Coatings Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Thromboresistant Coatings Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Thromboresistant Coatings Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Thromboresistant Coatings Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Thromboresistant Coatings Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Thromboresistant Coatings Sales Value (%), (2020-2031)

Figure 29. United States Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 35. China Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 37. China Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 47. India Thromboresistant Coatings Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Thromboresistant Coatings Sales Value by Type (%), 2024 VS 2031

Figure 49. India Thromboresistant Coatings Sales Value by Application (%), 2024 VS 2031

Figure 50. Thromboresistant Coatings Industrial Chain

Figure 51. Thromboresistant Coatings Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.3% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global Thromboresistant Coatings market? shouQi

What was the global market size of Thromboresistant Coatings in 2025? shouQi

What was the global market size of Thromboresistant Coatings in 2031? shouQi

What is the annual compound growth rate of the global Thromboresistant Coatings market size from 2025 to 2031? shouQi

Related Reports

Global Thromboresistant Coatings Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Thromboresistant Coatings market is projected to grow from US$ 1421 million in 2025 to US$ 2166 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 141
USD 4900.00
(Single User License)
Global Thromboresistant Coatings Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Thromboresistant Coatings market size was US$ 1421 million in 2025 and is forecast to reach a readjusted size of US$ 2166 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 100
USD 4250.00
(Single User License)
Global Thromboresistant Coatings Market Research Report 2026
The global Thromboresistant Coatings market was valued at US$ 1421 million in 2025 and is anticipated to reach US$ 2166 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 119
USD 2900.00
(Single User License)
Thromboresistant Coatings - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Thromboresistant Coatings was estimated to be worth US$ 1421 million in 2025 and is projected to reach US$ 2166 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 105
USD 3950.00
(Single User License)
Global Thromboresistant Coatings Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Thromboresistant Coatings market size was US$ 1345 million in 2024 and is forecast to a readjusted size of US$ 2050 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
Global Thromboresistant Coatings Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Thromboresistant Coatings market is projected to grow from US$ 1345 million in 2024 to US$ 2050 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 142
USD 4900.00
(Single User License)
Global Thromboresistant Coatings Market Research Report 2025
The global market for Thromboresistant Coatings was valued at US$ 1345 million in the year 2024 and is projected to reach a revised size of US$ 2050 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-03-10
Pages: 85
USD 2900.00
(Single User License)
Global Thromboresistant Coatings Market Insights, Forecast to 2030
Valued at US$ 1345 million in 2024, the global Thromboresistant Coatings market is forecast to reach US$ 1940 million by 2030, at a CAGR of 6.3% during the forecast period.
Published Date: 2024-11-29
Pages: 142
USD 4900.00
(Single User License)
Global and United States Thromboresistant Coatings Market Report & Forecast 2024-2030
The global Thromboresistant Coatings revenue was US$ 1265 million in 2023 and is forecast to a readjusted size of US$ 1940 million by 2030 with a CAGR of 6.3% during the review period (2024-2030).
Published Date: 2024-11-29
Pages: 120
USD 4350.00
(Single User License)
Thromboresistant Coatings- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Thromboresistant Coatings was estimated to be worth US$ 1265 million in 2023 and is forecast to a readjusted size of US$ 1940 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 115
USD 3950.00
(Single User License)

Global Thromboresistant Coatings Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Thromboresistant Coatings market is projected to grow from US$ 1421 million in 2025 to US$ 2166 million by 2032, at a CAGR of 6.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 141
USD 4900.00 (Single User License)
Global Thromboresistant Coatings Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Thromboresistant Coatings market size was US$ 1421 million in 2025 and is forecast to reach a readjusted size of US$ 2166 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 100
USD 4250.00 (Single User License)
Global Thromboresistant Coatings Market Research Report 2026
The global Thromboresistant Coatings market was valued at US$ 1421 million in 2025 and is anticipated to reach US$ 2166 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 119
USD 2900.00 (Single User License)
Thromboresistant Coatings - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Thromboresistant Coatings was estimated to be worth US$ 1421 million in 2025 and is projected to reach US$ 2166 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 105
USD 3950.00 (Single User License)
Global Thromboresistant Coatings Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Thromboresistant Coatings market size was US$ 1345 million in 2024 and is forecast to a readjusted size of US$ 2050 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
USD 4250.00 (Single User License)
Global Thromboresistant Coatings Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Thromboresistant Coatings market is projected to grow from US$ 1345 million in 2024 to US$ 2050 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 142
USD 4900.00 (Single User License)
Global Thromboresistant Coatings Market Research Report 2025
The global market for Thromboresistant Coatings was valued at US$ 1345 million in the year 2024 and is projected to reach a revised size of US$ 2050 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-03-10
Pages: 85
USD 2900.00 (Single User License)
Global Thromboresistant Coatings Market Insights, Forecast to 2030
Valued at US$ 1345 million in 2024, the global Thromboresistant Coatings market is forecast to reach US$ 1940 million by 2030, at a CAGR of 6.3% during the forecast period.
Published: 2024-11-29
Pages: 142
USD 4900.00 (Single User License)
Global and United States Thromboresistant Coatings Market Report & Forecast 2024-2030
The global Thromboresistant Coatings revenue was US$ 1265 million in 2023 and is forecast to a readjusted size of US$ 1940 million by 2030 with a CAGR of 6.3% during the review period (2024-2030).
Published: 2024-11-29
Pages: 120
USD 4350.00 (Single User License)
Thromboresistant Coatings- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Thromboresistant Coatings was estimated to be worth US$ 1265 million in 2023 and is forecast to a readjusted size of US$ 1940 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 115
USD 3950.00 (Single User License)